Matt Schmitt’s research shows hospital prices rise after acquisitions, even where local competition is unchanged
When beds are limited, turning away the sickest and poorest boosts margins
Pharmaceutical companies are better able to identify promising new applications for existing drugs
U.S. efforts to encourage transparency widely ignored by companies
Younger-patient mortality rate nearly triples, 20 years of data indicate
Information helps users decide when, and whether, to venture outside or exercise
Higher morbidity found where fewer staffers are vaccinated against COVID-19
A model outperformed simpler statistical approaches in predicting which patients would encounter trouble
Pharma companies less likely to disclose critical drug information than public institutions
Just putting one where the last cardiac arrest occurred isn’t optimal — more calculations to get to fewer steps
Poorer residents of states refusing to expand Medicaid hit hardest
Projects that make health care delivery more efficient require upfront financial help
Rate of spread in the surrounding community was a bigger indicator of risk
Tying payments to weight, rather than behaviors, marginally more effective
Bundled product offerings, team members who hog the glory and kidney transplant quality
Reliance on part-timers raises headcounts and dangers to patients